中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 36 Issue 8
Aug.  2020
Turn off MathJax
Article Contents

Clinical effect of local treatment based on limited segmental resection in improving the prognosis of liver oligometastasis after surgery for colorectal cancer

DOI: 10.3969/j.issn.1001-5256.2020.08.017
  • Published Date: 2020-08-20
  • Objective To investigate whether local treatment based on limited segmental resection can improve the prognosis of colorectal liver oligometastases(CRLOM) compared with other non-surgical treatment method,as well as the individualized regimen of this treatment method.Methods A retrospective analysis was performed for the clinical data of 74 CRLOM patients who underwent local treatment in The First Affiliated Hospital of Kunming Medical University from January 2012 to December 2018,and according to the treatment method,they were divided into surgical group with 39 patients and non-surgical group with 35 patients.Treatment regimen and complications were compared between the two groups.The t-test or the Mann-Whitney U test was used for comparison of continuous data between groups;the chi-square test or the Fisher's exact test was used for comparison of categorical data between groups.The Kaplan-Meier method was used to plot survival curves and calculate median disease-free survival(DFS) time and overall survival(OS) time,and the log-rank test was used for survival analysis.Results Among the 39 patients in the surgical group,23 underwent laparotomy and 16 underwent laparoscopy;as for the surgical procedure,11 underwent limited segmental/subsegmental resection alone,21 underwent limited segmental/subsegmental resection combined with wedge resection of small lesions,and 7 underwent limited segmental/subsegmental resection combined with radiofrequency ablation(RFA);5 patients experienced postoperative complications,with bleeding in 1 patient,biliary fistula in 1 patient,and pleural effusion in 3 patients.Among the 35 patients in the non-surgical group,18 underwent ultrasound-or CT-guided RFA combined with transarterial chemoembolization(TACE),5 underwent TACE alone,9 underwent RFA,and 3 underwent stereotactic body radiotherapy;as for postoperative complications,1 patient experienced liver abscess after TACE,and 1 experienced pneumothorax after RFA.No patient died within 30 days after treatment.The surgical group had a DFS time of 38 months(95% confidence interval [CI]:31.3-44.9)and an OS time of 27 months(95% CI:19.9-34.0),and the non-surgical group had a DFS time of 64 months(95% CI:57.6-70.1)and an OS time of 43 months(95% CI:36.2-50.0),with significant differences between the two groups(χ2=6.072 and 11.685,P=0.014 and 0.001).The surgical group had a 1-year survival rate of 92.3% and a 5-year survival rate of 41.0%,while the non-surgical group had a 1-year survival rate of 82.8% and a 5-year survival rate of 14.3%.Conclusion Compared with non-local surgical treatment,local treatment based on limited segmental resection can significantly improve the prognosis of CRLOM in patients with colorectal cancer.The surgical procedure should be individualized according to lesion characteristics.

     

  • loading
  • [1] CREASY JM,SADOT E,KOERKAMP BG,et al. Actual 10-year survival after hepatic resection of colorectal liver metastases:What factors preclude cure?[J]. Surgery,2018,163(6):1238-1244.
    [2] ZHANG ZQ. Analysis of prognostic factors for patients treated by radical resection of liver metastases from colorectal cancer[J]. J Clin Hepatol,2015,31(9):1455-1457.(in Chinese)张志泉.结直肠癌肝转移患者行肝根治性切除术的预后影响因素分析[J].临床肝胆病杂志,2015,31(9):1455-1457.
    [3] LIU X,LIU F,LIU YF,et al. Clinical effect of intraoperative laparotomic color Doppler ultrasound-guided radiofrequency versus percutaneous CT-guided radiofrequency in treatment of colorectal cancer liver metastasis[J]. Clin J Med Offic,2020,48(2):167-169.(in Chinese)刘信,刘放,刘也夫,等.术中开腹彩超引导下射频与经皮CT引导射频治疗结直肠癌肝转移疗效比较研究[J].临床军医杂志,2020,48(2):167-169.
    [4] IMAI K,ALLARD MA,BENITEZ CC,et al. Early recurrence after hepatectomy for colorectal liver metastases:What optimal definition and what predictive factors?[J]. Oncologist,2016,21(7):887-894.
    [5] LI MJ,CHEN D,CHEN WB. Effects ofβ-adrenergic receptor blockers and COX-2 inhibitors on liver metastasis of colorectal cancer[J]. Chin J Clin Pharmacol Ther,2018,23(8):893-899.(in Chinese)李敏江,陈栋,陈文斌.β-肾上腺素能受体阻滞剂和COX-2抑制剂在结直肠癌肝转移中的作用研究[J].中国临床药理学与治疗学,2018,23(8):893-899.
    [6] DEXIANG Z,LI R,YE W,et al. Outcome of patients with colorectal liver metastasis:Analysis of 1613 consecutive cases[J]. Ann Surg Oncol,2012,19(9):2860-2868.
    [7] BENSON AB,VENOOK AP,CEDERQUIST L,et al. Colon Cancer,Version 1,2017,NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw,2017,15(3):370-398.
    [8] LORDAN JT,ROBERTS JK,HODSON J,et al. Case-controlled study comparing peri-operative and cancer-related outcomes after major hepatectomy and parenchymal sparing hepatectomy for metastatic colorectal cancer[J]. HPB(Oxford),2017,19(8):688-694.
    [9] MISE Y,ALOIA TA,BRUDVIK KW,et al. Parenchymal-paring hepatectomy in colorectal liver metastasis improves salvageability and survival[J]. Ann Surg,2016,263(1):146-152.
    [10] MEMEO R,de BLASI V,ADAM R,et al. Parenchymal-sparing hepatectomies(PSH)for bilobar colorectal liver metastases are associated with a lower morbidity and similar oncological results:A propensity score matching analysis[J]. HPB(Oxford),2016,18(9):781-790.
    [11] IMAI K,ALLARD MA,CASTRO BC,et al. Nomogram for prediction of prognosis in patients with initially unresectable colorectal liver metastasis[J]. Br J Surg,2016,103(5):590-599.
    [12] BRUDVIK KW,JONES RP,GIULIANTE F,et al. RAS mutation clinical risk score to predict survival after resection of colorectal liver metastases[J]. Ann Surg,2019,269(1):120-126.
    [13] MARGONIS GA,SASAKI K,GHOLAMI S,et al. Genetic and Morphological Evaluation(GAME)score for patients with colorectal liver metastases[J]. Br J Surg,2018,105(9):1210-1220.
    [14] van CUTSEM E,CERVANTES A,ADAM R,et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer[J]. Ann Oncol,2016,27(8):1386-1422.
    [15] MATSUKI R,MISE Y,SAIURA A,et al. Parenchymal-sparing hepatectomy for deep-placed colorectal liver metastases[J]. Surgery,2016,160(5):1256-1263.
    [16] TORZILLI G,ADAM R,VIGANL,et al. Surgery of colorectal liver metastases:Pushing the limits[J]. Liver Cancer,2016,6(1):80-89.
    [17] VIGANL,PROCOPIO F,CIMINO MM,et al. Is tumor detachment from vascular structures equivalent to R0 resection in surgery for colorectal liver metastases? An observational cohort[J]. Ann Surg Oncol,2016,23(4):1352-1360.
    [18] URBANI L,COLOMBATTO P,BALESTRI R,et al. Techniques of parenchyma-sparing hepatectomy for the treatment of tumors involving the hepatocaval confluence:A reliable way to assure an adequate future liver remnant volume[J]. Surgery,2017,162(3):483-499.
    [19] SASAKI K,MARGONIS GA,MAITANI K,et al. The prognostic impact of determining resection margin status for multiple colorectal metastases according to the margin of the largest lesion[J]. Ann Surg Oncol,2017,24(9):2438-2446.
    [20] DING XY,CHEN JL,SUN W,et al. Influence of time schedule of radiofrequency ablation on the safety and prognosis of patients with colorectal cancer liver metastasis receiving XELOX regimen:A single-center clinical study[J]. J Clin Hepatol,2018,34(12):2603-2609.(in Chinese).丁晓燕,陈京龙,孙巍,等.射频消融先后顺序对XELOX方案治疗结直肠癌肝转移患者安全性和预后的影响[J].临床肝胆病杂志,2018,33(12):2603-2609.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1215) PDF downloads(186) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return